Seasoned investor and operating executive focused on growth-stage and middle-market opportunities across technology and industrials. John Derrick leverages corporate finance and M&A experience to source deals, lead operational turnarounds, and serve on boards. Known for hands-on portfolio management, capital structure optimization and exit planning, often working with PE sponsors, strategic acquirers and management teams to drive scaled revenue and margin expansion.
Seasoned investor and operating executive focused on growth-stage and middle-market opportunities across technology and industrials. John Derrick leverages corporate finance and M&A experience to source deals, lead operational turnarounds, and serve on boards. Known for hands-on portfolio management, capital structure optimization and exit planning, often working with PE sponsors, strategic acquirers and management teams to drive scaled revenue and margin expansion.
Targets growth-stage and middle-market companies in technology and industrials, deploying a hands-on, operationally driven private equity style. Prefers control or significant minority positions that enable active board involvement, capital structure optimization and performance turnarounds. Investment horizon is medium-term with value creation via revenue scaling, margin expansion and selective M&A. Underwrites with rigorous corporate finance and cash-flow disciplines, partners with PE sponsors and strategic acquirers, and prioritizes clear exit pathways to maximize realized IRR.
Targets growth-stage and middle-market companies in technology and industrials, deploying a hands-on, operationally driven private equity style. Prefers control or significant minority positions that enable active board involvement, capital structure optimization and performance turnarounds. Investment horizon is medium-term with value creation via revenue scaling, margin expansion and selective M&A. Underwrites with rigorous corporate finance and cash-flow disciplines, partners with PE sponsors and strategic acquirers, and prioritizes clear exit pathways to maximize realized IRR.
| Trades 284 | Longs Won 183/284 64% | Profit Factor 4.2 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $1.79M |
| Average Win $913,373.14 | Best Trade (Aug 14) $13.5M | Sharpe Ratio -9.96 |
| Average Loss -$394,280.11 | Worst Trade (Aug 02) -$4.72M | Z-Score 4.58 (100%) |
| Commissions $0 | Avg. Trade Length 1y 4m 3w 6d | Expectancy $448,327.44 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 1,109 | 998 | 887 | 776 | 665 | 554 | 443 | 333 | 222 | 111 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
ACN Accenture plc Class A | 56,080 | $16.88M | $9.3M | - | -$7.57M | -44.87% | +1.611% |
ASML ASML Holding N.V. New York Registry Shares | 13,812 | $11.07M | $22.5M | - | $11.43M | 103.27% | -1.359% |
BNS Bank of Nova Scotia | 205,242 | $10.43M | $18.01M | - | $7.58M | 72.67% | -0.08% |
BRK-B Berkshire Hathaway Inc. | 30,663 | $11.96M | $15.69M | - | $3.72M | 31.11% | +0.365% |
CALM Cal-Maine Foods Inc. | 132,449 | $8.55M | $11.63M | - | $3.07M | 35.95% | +0.804% |
CMI Cummins Inc. | 26,782 | $7.63M | $16.99M | - | $9.35M | 122.57% | +0.193% |
COF Capital One Financial Corporation | 62,921 | $13.31M | $13.15M | - | -$160,268.38 | -1.2% | -0.538% |
DE Deere & Company | 30,586 | $14.6M | $18.13M | - | $3.53M | 24.18% | -1.134% |
EMR Emerson Electric Co. | 103,551 | $10.65M | $15.51M | - | $4.87M | 45.7% | +0.794% |
GOOG Alphabet Inc | 1,218 | $216,061 | $434,399.69 | - | $218,338.69 | 101.05% | +6.884% |
GOOGL Alphabet Inc | 74,290 | $11.91M | $26.46M | - | $14.54M | 122.05% | +6.734% |
IBOC International Bancshares Corporation | 127,460 | $7.16M | $9.76M | - | $2.6M | 36.34% | +0.262% |
ICLR ICON plc | 134,248 | $20.5M | $21.96M | - | $1.46M | 7.11% | -1.184% |
JBHT J.B. Hunt Transport Services, Inc. | 84,910 | $13.32M | $23.07M | - | $9.76M | 73.27% | +0.944% |
LRCX Lam Research Corporation | 71,251 | $6.7M | $20.88M | - | $14.18M | 211.59% | -1.579% |
MRK Merck & Co., Inc. | 116,413 | $12.74M | $15.16M | - | $2.41M | 18.95% | +0.316% |
MTN Vail Resorts, Inc. | 87,702 | $11.66M | $13.1M | - | $1.44M | 12.34% | -2.251% |
NVO Novo Nordisk A/S Sponsored ADR | 163,661 | $15.05M | $7.71M | - | -$7.35M | -48.81% | -8.777% |
NVS Novartis AG Sponsored ADR | 80,627 | $8.92M | $12.59M | - | $3.67M | 41.21% | -1.445% |
PEP PepsiCo, Inc. | 97,005 | $15.4M | $13.54M | - | -$1.86M | -12.1% | -0.456% |